Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oxford Biomedica Share News (OXB)
OXB Share
Price
OXB Share
News
OXB Share
Chat
OXB Share
Trades528
OXB
Live RNS
OXB Share
Charts
OXB Level 2
Console
OXB Live
Share Price
OXB Broker
Ratings
OXB Directors
Deals
OXB Financial
Diary
OXB
Fundamentals
OXB Short
Positions1
OXB
Media
OXB Company
Research
OXB Company
Timeline1
Share Price Information for Oxford Biomedica (OXB)
Last checked at -
Last checked at 
Intraday Oxford Biomedica Share Chart
Oxford Biomedica News
IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an ...
Oxford BioMedica shares up as license deal signed with new US partner
(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner.
Oxford Biomedica inks LSA with new US biotech partner
(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck a new licence and supply agreement with an unnamed US partner.
EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by...
SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.
Oxford BioMedica begins new project and signs license agreement
(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement.
Oxford Biomedica inks LSA with US biotech firm, launches new project with Orchard Therapeutics
(Sharecast News) - Gene and cell therapy group Oxford Biomedica inked a new licence and supply agreement with an unnamed US private biotechnology on T...
Follow the stocks
